Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo-Reference-Cited by-同舟云学术

Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo

Published:2019-10-24 Issue:6 Volume:32 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Shah Bela¹,Godse Kiran²,Mahajan Satyaprakash³,Grandhi Sudhakarrao⁴,Shendkar Sonal⁵,Sharma Akhilesh⁶,Teli Chirag⁶,Pathak Rahul⁶,Parsad Davinder⁷^ORCID

Affiliation:

1. Department of DermatologyB.J. Medical College & Civil Hospital Ahmedabad India

2. Department of DermatologyD.Y. Patil Medical College Navi Mumbai India

3. Supe Hospital & Research Centre Nashik India

4. Medipoint Hospital Pune India

5. Lifepoint Multispecialty Hospital Pune India

6. Medical Services, Alkem Laboratories Ltd. India

7. Department of DermatologyPostgraduate Institute of Medical Education & Research Chandigarh India

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13109

Reference12 articles.

1. Melanocyte growth factor deprivation is intertwined with oxidative stress and autoimmune theories in the etiology of vitiligo: A basis for treating vitiligo, 14th international conference on clinical and experimental dermatology June 19‐20 Philadelphia, USA. Posters & Accepted Abstracts;Abburi R.;Journal of Clinical and Experimental Dermatology Research,2017

2. Update on skin repigmentation therapies in vitiligo

3. Comparative study of efficacy and safety of topical active fragment of basic fibroblast growth factor (B FGF) 0.1% solution V/S betamethasone valerate 0.1% ointment in the treatment of vitiligo patients;Kamala Subhashini P.;IOSR Journal of Dental and Medical Sciences,2015

4. A review of the worldwide prevalence of vitiligo in children/adolescents and adults

5. Vitiligo as an Autoimmune Disease

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK9 Inhibitors and the Risk of Vitiligo: A Mendelian Randomization Study;Journal of Investigative Dermatology;2024-08

2. Vitiligo: Pathogenesis and New and Emerging Treatments;International Journal of Molecular Sciences;2023-12-09

3. Development of Consensus Recommendations on the Management of Vitiligo and the Role of Decapeptide in Vitiligo by the Delphi Method;Indian Journal of Dermatology;2023-09

4. An Erythematous Plaque on the Nose;Indian Journal of Dermatology;2023-09

5. The Safety and Effectiveness of Decapeptide in Patients With Vitiligo: A Real-World Study;Cureus;2023-07-05